How do things go for people born with extremely low birth weight? A new Swedish study shows that most of them are leading independent lives, participate in work or education, and have established relationships by the time they reach their late 20s. At the same time, slightly fewer have moved out of their parents' home, entered the labor market or ever been in a romantic relationship compared with people born following a full-term pregnancy.
Results for “stock market”
Two telehealth giants rolled out peptide programs this week after HHS made it easier for compounding pharmacies to offer drugs like BPC-157.
In this edition of AI Prognosis: A closer look at how the AI scribe market is shaking out, news from the HLTH conference, and more
China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.
For school kids with severe food allergies, having epinephrine on hand at school can mean the difference between a scary moment and a life-threatening one. A new national survey of school nurses presented at the 2026 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI), held Nov. 12–16 in Phoenix, looks at how schools stock and manage this lifesaving medicine.
Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.
Ionis Pharmaceuticals lost more than $1 billion in market value on Monday after the company slashed sales projections for a triglyceride-lowering drug.
The U.S. Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries.
Amish and Mennonite shoppers in conservative dress mingled with shoppers from the wider public on a recent Friday at a vast outdoor market here, where vendors sold colorful pumpkins and mums, fry pies and squash, sports jerseys and Barbie accessories.
Concerns raised as big private firms buy up care homes and home help fragmenting in England.
The BBC's Annabel Rackham shares some dos and don'ts, following government advice in case of food supply chain disruption.
This is a MedPage Today story. A new journal purports to improve the publishing process through open access and public peer review, but it was co-founded by researchers who challenged the U.S. response to COVID-19 -- including President Trump's pick to lead the NIH, Jay Bhattacharya, MD, PhD. Bhattacharya and Martin Kulldorff, PhD, have founded the Journal of the Academy of Public Health, where "good scientists can publish whatever their studies conclude," Kulldorff said in a post on X. Kulldorff reported the backdrop for launching the journal in a perspective, charging that commercial publishers have a corner on the market, with universities paying "an enormous amount of money for journals that contain articles that are both written and peer reviewed by their own scientists, which they provide to journals for free." "As a result, scientific journal publishers have huge profit margins reaching almost 40%," Kulldorff stated in the perspective. Unlike traditional publishing,...











